NIH awards OHSU scientists, collaborators $8.4 million to develop a cure for HIV
Only a handful of people in history have been cured of the virus; three have agreed to kick off landmark research project led by OHSU.
Research
More Research Stories
- Latest Stories
OHSU investigators awarded $3 million for innovative, promising research
January 24, 2022
New funds for leading-edge research on malaria vaccines, emerging viral diseases, gun violence prevention, gene regulatory control.
Human brain mapping with groundbreaking resolution
January 21, 2022
New sensor grids could transform precision of neurosurgery, expand understanding of the brain.
Review reports improved transparency in antidepressant drug trials
January 19, 2022
Negative study findings, ‘once a dirty little secret,’ are now being acknowledged more often.
Study shows hemp compounds prevent coronavirus from entering human cells
January 13, 2022
Laboratory research is a collaboration of researchers at OHSU, Oregon State University.
Cannabis resource for health care providers, researchers launches Jan. 10
January 10, 2022
Web-based platform includes updated information about health effects of cannabis, searchable compilation of latest research.
COVID-19 vaccine may temporarily alter menstrual cycle length, should not be cause for concern
January 06, 2022
Research shows an average change of less than one day in overall cycle duration following vaccination, no changes to period length.
Pathway to better eye health runs through the gut
December 21, 2021
Ocular inflammation research by Phoebe Lin, M.D., Ph.D., targets gastrointestinal microbes.
Breakthrough infections generate ‘super immunity’ to COVID-19, study suggests
December 16, 2021
COVID-19 vaccination provides a foundation of protection that’s enhanced by breakthrough infection; ‘the key is to get vaccinated.'
OHSU receives more than $3 million to study effects of Project Nurture rural expansion
December 16, 2021
Five-year analysis will observe impacts of novel substance abuse treatment program for pregnant individuals, help identify opportunities for future growth, implementation.
Massive cost, meager benefit
December 13, 2021
Evidence review reveals little, if any, clinical benefit to drug that costs Medicare hundreds of millions of dollars annually